Literature DB >> 11124402

Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats.

S Schenk1.   

Abstract

Manipulations of serotonergic systems have been shown to modify many of the behavioral effects of cocaine. It was recently demonstrated that serotonin (5-HT) depletions produced by inhibition of tryptophan hydroxylase reduced cocaine-seeking in an animal model. The present study was designed to determine whether pretreatment with specific 5-HT antagonists might also decrease cocaine-seeking. The effect of pretreatment with the 5-HT(2) antagonist, ritanserin (0.0, 1.0, or 10.0 mg/kg), or the 5-HT(1A) antagonist, WAY 100635 (0. 0, 0.1, 0.3, or 1.0 mg/kg), on cocaine (5.0, 10.0, or 20.0 mg/kg)-produced reinstatement of extinguished drug-taking behavior was measured. Although ritanserin was ineffective, WAY 100635 attenuated cocaine-produced reinstatement in a dose-dependent manner. These effects of WAY 100635 appeared to be specific since responding maintained by saccharin self-administration remained high following pretreatment with 0.3 or 1.0 mg/kg WAY 100635. These data suggest a role of 5-HT(1A), but not 5-HT(2), receptors in cocaine-seeking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11124402     DOI: 10.1016/s0091-3057(00)00377-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  18 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

2.  Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats.

Authors:  S Schenk; D Gittings; J Colussi-Mas
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats.

Authors:  Susan Schenk; Dave Gittings
Journal:  Psychopharmacology (Berl)       Date:  2002-11-05       Impact factor: 4.530

Review 4.  Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Authors:  Kathryn A Cunningham; Noelle C Anastasio
Journal:  Neuropharmacology       Date:  2013-07-11       Impact factor: 5.250

Review 5.  The reinstatement model and relapse prevention: a clinical perspective.

Authors:  David H Epstein; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

6.  Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats.

Authors:  T H C Cheung; B C Nolan; L R Hammerslag; S M Weber; J P Durbin; N A Peartree; R H Mach; R R Luedtke; J L Neisewander
Journal:  Neuropharmacology       Date:  2012-08-31       Impact factor: 5.250

7.  Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats.

Authors:  Keith L Shelton; Elizabeth S Hendrick; Patrick M Beardsley
Journal:  Drug Alcohol Depend       Date:  2013-01-29       Impact factor: 4.492

Review 8.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1 mg/kg.

Authors:  Dmitry V Zaretsky; Maria V Zaretskaia; Joseph A DiMicco; Daniel E Rusyniak
Journal:  Neurosci Lett       Date:  2015-09-12       Impact factor: 3.046

10.  Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaine.

Authors:  Brian C Nolan; Shinban Liu; Lindsey R Hammerslag; Timothy H C Cheung; Jeffrey Lenz; Robert H Mach; Robert R Luedtke; Janet L Neisewander
Journal:  Synapse       Date:  2013-07-17       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.